GeneSort vs Immunai
GeneSort vs Immunai, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: GeneSort is on 39/100 and Immunai on 69/100.
Where each one leads
GeneSort
Leads on none of the measures we hold for both companies.
Immunai
- our overall score: 69/100 against 39/100
- agent readiness: 32/100 against 21/100
- domain rating: 46/100 against 3/100
- headcount: 179 against 4
- headcount growth: +13.0% against -4.9%
- funding raised: $295M against $2.2M
- LinkedIn following: 26,832 against 622
At a glance
| Measure | GeneSort | Immunai |
|---|---|---|
| What it is | A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer. | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. |
| Category | Healthcare, Next Generation Sequencing, Cancer, Genomics | Healthcare, Immunology, Data, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2014 | 2019 |
| Headquarters | Tel Aviv, Israel | New York, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | GeneSort | Immunai |
|---|---|---|
| Employees | 4 | 179 |
| Headcount growthLast 12 months | -4.9% | +13.0% |
| Total funding | $2.2M | $295M |
| Latest round | Not published | Series B |
| Valuation | Not published | $1.0B |
| LinkedIn followers | 622 | 26,832 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | GeneSort | Immunai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 69/100 |
| Traction | 39/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 24/100 | 39/100 |
| Quality | 48/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 3/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | GeneSort | Immunai |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
GeneSort vs Immunai: common questions
Which is better, GeneSort or Immunai?
On our 0-100 score Immunai rates higher (69/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do GeneSort and Immunai compare on the numbers?
Immunai leads on our overall score (69/100 against 39/100), agent readiness (32/100 against 21/100), domain rating (46/100 against 3/100), headcount (179 against 4), headcount growth (+13.0% against -4.9%), funding raised ($295M against $2.2M), LinkedIn following (26,832 against 622).
Read the full GeneSort review and pricing or the Immunai review and pricing. You can also browse other GeneSort alternatives we track.